Arch Therapeutics, Inc. (OTCMKTS:ARTH – Get Free Report) crossed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $0.21 and traded as low as $0.20. Arch Therapeutics shares last traded at $0.20, with a volume of 5,011 shares trading hands.
Arch Therapeutics Stock Performance
The firm has a fifty day simple moving average of $0.21 and a two-hundred day simple moving average of $0.25.
Arch Therapeutics Company Profile
Arch Therapeutics, Inc, together with its subsidiaries, operates as a biotechnology company in the United States. It develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease.
Recommended Stories
- Five stocks we like better than Arch Therapeutics
- What is the Dogs of the Dow Strategy? Overview and Examples
- Quantum Computing: The $6.5 Billion Opportunity You Can’t Ignore
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Are Tariffs Threatening Disney’s Comeback Story?
- Are Penny Stocks a Good Fit for Your Portfolio?
- Is Alphabet a Generational Buying Opportunity at These Levels?
Receive News & Ratings for Arch Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arch Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
